Skip to main content

Corporate insider profile

Chris Degnan Insider Trades

Latest reported as Chief Financial Officer of UroGen Pharma Ltd. (URGN).

Purchase filings
0
Reported companies
1
Net open-market value
-$80,791.38
Latest transaction
Oct 8, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 8, 2026UroGen Pharma Ltd. (URGN)Chief Financial OfficerSale2,202$36.69$80,791